Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00758_DB06414_nanopub.RA_HXT0JtF2MqgSnkjKmR2b-Rg6jwmE98RU1XcIsm286A#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00758_DB06414 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00758_DB06414 label "DDI between Clopidogrel and Etravirine - Clopidogrel, when used concomitantly with etravirine (a CYP2C19 inhibitor), may experience a decrease in the serum concentrations of it's active metabolites. Caution and close monitoring for decreased efficacy of clopidogrel is recommended. [drugbank_resource:DB00758_DB06414]" assertion.
- drugbank_resource:DB00758_DB06414 identifier "drugbank_resource:DB00758_DB06414" assertion.
- drugbank_resource:DB00758_DB06414 title "DDI between Clopidogrel and Etravirine - Clopidogrel, when used concomitantly with etravirine (a CYP2C19 inhibitor), may experience a decrease in the serum concentrations of it's active metabolites. Caution and close monitoring for decreased efficacy of clopidogrel is recommended." assertion.
- drugbank:DB00758 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00758_DB06414 assertion.
- drugbank:DB06414 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00758_DB06414 assertion.